Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.
Qu WF, Tian MX, Lu HW, Zhou YF, Liu WR, Tang Z, Yao Z, Huang R, Zhu GQ, Jiang XF, Tao CY, Fang Y, Gao J, Wu XL, Chen JF, Zhao QF, Yang R, Chu TH, Zhou J, Fan J, Yu JH, Shi YH. Qu WF, et al. Among authors: wu xl. Hepatol Int. 2023 Aug;17(4):927-941. doi: 10.1007/s12072-023-10511-2. Epub 2023 Apr 8. Hepatol Int. 2023. PMID: 37031334 Free PMC article.
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.
Fang Y, Liu W, Tang Z, Ji X, Zhou Y, Song S, Tian M, Tao C, Huang R, Zhu G, Jiang X, Gao J, Qu W, Wang H, Zhou P, Wu X, Jin L, Sun H, Ding Z, Peng Y, Zhao S, Zhou J, Fan J, Xu W, Shi Y. Fang Y, et al. Hepatology. 2023 Jan 1;77(1):109-123. doi: 10.1002/hep.32348. Epub 2022 Feb 7. Hepatology. 2023. PMID: 35043976
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study.
Qu WF, Ding ZB, Qu XD, Tang Z, Zhu GQ, Fu XT, Zhang ZH, Zhang X, Huang A, Tang M, Tian MX, Jiang XF, Huang R, Tao CY, Fang Y, Gao J, Wu XL, Zhou J, Fan J, Liu WR, Shi YH. Qu WF, et al. Among authors: wu xl. BJS Open. 2022 Sep 2;6(5):zrac114. doi: 10.1093/bjsopen/zrac114. BJS Open. 2022. PMID: 36125345 Free PMC article.
CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.
Zhu GQ, Tang Z, Huang R, Qu WF, Fang Y, Yang R, Tao CY, Gao J, Wu XL, Sun HX, Zhou YF, Song SS, Ding ZB, Dai Z, Zhou J, Ye D, Wu DJ, Liu WR, Fan J, Shi YH. Zhu GQ, et al. Among authors: wu xl, wu dj. Cell Discov. 2023 Mar 6;9(1):25. doi: 10.1038/s41421-023-00529-z. Cell Discov. 2023. PMID: 36878933 Free PMC article.
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma.
Liu W, Wang H, Zhao Q, Tao C, Qu W, Hou Y, Huang R, Sun Z, Zhu G, Jiang X, Fang Y, Gao J, Wu X, Yang Z, Ping R, Chen J, Yang R, Chu T, Zhou J, Fan J, Tang Z, Yang D, Shi Y. Liu W, et al. Cancer Commun (Lond). 2024 Feb;44(2):226-250. doi: 10.1002/cac2.12513. Epub 2023 Dec 24. Cancer Commun (Lond). 2024. PMID: 38143235 Free PMC article.
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration.
Tao CY, Wu XL, Song SS, Tang Z, Zhou YF, Tian MX, Jiang XF, Fang Y, Zhu GQ, Huang R, Qu WF, Gao J, Chu TH, Yang R, Chen JF, Zhao QF, Ding ZB, Dai Z, Zhou J, Liu WR, Shi YH, Fan J. Tao CY, et al. Among authors: wu xl. Cell Oncol (Dordr). 2024 Apr 12. doi: 10.1007/s13402-024-00934-w. Online ahead of print. Cell Oncol (Dordr). 2024. PMID: 38607517
1,334 results